Skip to content

A Pilot Study Examining the Efficacy of Biomodulator Treatment for Chronic Low Back Pain

A Pilot Study Examining the Efficacy of Biomodulator Treatment for Chronic Low Back Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02707094
Enrollment
75
Registered
2016-03-14
Start date
2013-01-31
Completion date
2016-08-31
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

back, pain, chronic

Brief summary

The purpose of this study is to determine the efficacy of self treatment with the Biomodulator device to decrease chronic low back pain (LBP) in active duty service members. In addition, the study will track the use of pain medication and the impact of pain on symptoms of anxiety, depression and Post Traumatic Stress Syndrome (PTSD).

Interventions

DEVICEBiomodulator

The Biomodulator is a type of very low frequency TENS known as pulsed electromagnetic field therapy (PEMF). Unlike TENS devices that deliver 1-80 milliamperes of electrical current, PEMF devices deliver short bursts of electrical microamperes (millionths of an ampere) to injured tissues without producing heat or interfering with nerve or muscle function. Micro-current levels between 20-500 microampere appear to be most effective at relieving pain and inflammation and promoting tissue healing by realigning the natural electrical balance that exists within the cells that has become disrupted due to injury.

OTHERUsual Care (Medication + Exercise)

The study LP will prescribe an analgesic medication regimen based on the participant's needs. These medications may consist of Non-steroidal anti-inflammatory Drugs (NSAIDs) (ibuprofen, naproxen sodium, etc.), muscle relaxants (Flexeril, Robaxin, valium, etc.), non-narcotic analgesic medications (acetaminophen, aspirin, tramadol, etc.), or narcotic medications (Tylenol #3, Percocet, Vicodin, etc.) depending on the severity of their pain and co-morbid conditions. The RC will also provide instructions for LBP stretching and strengthening exercises. The following exercises will be recommended as a daily regimen: the partial curl, cat and camel, pelvic tilt, quadriceps, arm/leg raises,trunk rotation, single knee to chest stretch, standing hamstring stretch, and double knee to chest stretch.

Sponsors

Brooke Army Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 62 Years
Healthy volunteers
No

Inclusion criteria

* active duty Service Members (SMs) between the ages of 18 and 62, inclusive * history of chronic LBP (i.e. intermittent or continuous LBP symptoms present for 3 months or greater prior to entry into the study * participants must be using narcotic and/or non-narcotic oral analgesic medications to treat their chronic LBP symptoms on a weekly basis * must be able to speak and read English and understand the study procedures

Exclusion criteria

* pacemaker or implanted electronic device * history of stroke, blood clots, or cardiac arrhythmias * pregnancy * no self-reported history of prescription medication abuse or sole-provider contract for prescribed narcotic medications * open wound over site of chronic pain; * history of spinal surgery * participation in a clinical trial for an investigational drug/ treatment within last 30 days * undergone treatment with TENS, biofeedback, or acupuncture within last 30 days * prior treatment with the Biomodulator * LBP red flags: fever, trauma, progressive motor or sensory deficit, saddle anesthesia * participation in the study would delay the medical board (MEB) processing of the service member off of active duty status or would delay a return to duty status to their home unit

Design outcomes

Primary

MeasureTime frame
Change over time on the Numerical Rating Scale-11 Pain Score (NRS-11)Week 0, week 5, week 9

Secondary

MeasureTime frameDescription
Change over time on the Generalized Anxiety Disorder - 7 (GAD-7)Week 0, week 5, week 9
Change over time on the Posttraumatic Stress Disorder Checklist - Military (PCL-M) at week 5Week 0, week 5, week 9
Change over time on the Pittsburgh Sleep Quality Index (PSQI)Week 0, week 5, week 9
Change over time on the Oswestry Disability Questionnaire (ODQ)Week 0, week 5, week 9
Change over time on the Patient Health Questionnaire -9 (PHQ-9)Week 0, week 5, week 9
Change over time on the Interpersonal Relationships Inventory Short Form (IPRI-SF)Week 0, week 5, week 9
2 questions on treatment perceptionweek 51. Did you feel this treatment intervention was a success or failure (select one)? Complete Success Partial Success Partial Failure Complete Failure Explain why. 2. Did you find it easy or difficult to adhere to the treatment plan (select one)? Very Easy Somewhat Easy Somewhat Difficult Very Difficult Explain why.
Abbreviated acceptability rating profile - modified (AARP)week 5Acceptability
Change over time on oral consumption of analgesic medicationsWeek 0, week 5, week 9
Change over time on the Quality of Life - Health Survey (SF-12)Week 0, week 5, week 9

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026